-
Featured
Proving Efficacy of Two Non-Drug Therapies for Hypertension
Research at the Massachusetts General Hospital Heart Center proves the effectiveness of the relaxation response and renal denervation to control high blood pressure.
-
Acetylcholine Derived From B Cells May Protect Against Cardiovascular Disease
B cells in the bone marrow are an important source of acetylcholine, Massachusetts General Hospital researchers have discovered. B cell–derived acetylcholine regulated normal hematopoiesis and limited emergency hematopoiesis in cardiovascular disease by modulating signals produced by the bone marrow stromal niche.
-
Review: Cardiometabolic–Renal Comorbidities in Gout
Hyon K. Choi, MD, Chio Yokose, MD, MS, and Natalie McCormick, PhD, of the Division of Rheumatology, Allergy and Immunology, suggest pharmacologic agents that can both lower urate levels in patients with gout and treat common cardiometabolic-renal comorbidities of the disease.
-
Bone Marrow Vascular Pathologies Augment Supply of Leukocytes Implicated in CVD
Researchers from the Center for Systems Biology at Massachusetts General Hospital and colleagues address how three heart disease milestones—hypertension, atherosclerosis and myocardial infarction—impair the bone marrow's vascular health, suggesting a new direction for development of cardiovascular disease therapies.
-
AI Identifies Links Between Retinal Vascular Patterns and Risk of Cardiometabolic, Ocular Diseases
Measurements of retinal vascular density and branching, obtained from fundus photographs by convolutional neural networks at Massachusetts General Hospital, may be clinically useful as biomarkers of cardiometabolic disease severity and for predicting future risk of ocular diseases.
-
Using Renal Denervation to Treat Hypertension
Massachusetts General Hospital is one of few sites worldwide participating in research exploring the efficacy and safety of renal denervation to treat hypertension.
Hypertension Contributors
-
Alison S. Witkin, MD
Associate Director, Pulmonary Hypertension and Thromboendarterectomy Program, Massachusetts General Hospital
Recent Article
Studies Work to Improve Pulmonary Hypertension and HHT Care
-
Gregory D. Lewis, MD
Section Head, Heart Failure, Director, Cardiopulmonary Exercise Testing Laboratory, Medical Director, Cardiology ICU and Mechanical Circulatory Support Program
Recent Article
Blood Pressure Assessment During Exercise Testing Aids Risk Stratification of Patients With Heart Failure
-
Jennifer E. Ho, MD
Cardiologist, Heart Failure and Transplantation Program, Assistant Professor of Medicine, Harvard Medical School
Recent Article
Arterial Stiffness and Load Significantly Higher in Women Than Men With HFpEF
-
Josanna M. Rodriguez-Lopez, MD
Director, HHT Center, Director, Pulmonary Hypertension and Thromboendarterectomy Program
Recent Article
Studies Work to Improve Pulmonary Hypertension and HHT Care
-
Pradeep Natarajan, MD, MMSc
Director, Preventive Cardiology, Associate Professor of Medicine, Harvard Medical School
Recent Article
Lipoprotein(a) Prognostic of CHD in Contemporary Cohort Receiving Menopausal Hormone Therapy
-
Randall Mark Zusman, MD
Director, Division of Hypertension
Recent Article
Using Renal Denervation to Treat Hypertension
Cardiovascular Care at Mass General
At Mass General, our world-class physicians and nurses specialize in specific forms of both heart and vascular disease, and work closely together to offer leading treatments and preventive care for cardiovascular conditions.